Showing 12 out of 54 results
THE UPC AND THE UP: IMPACT ON PATENT PORTFOLIOS, CO-OWNERSHIP AND LICENSING
For information on the impact of the UP and the UPC on the management of patent applications, patent portfolios in general and licensing see our two part …
How to get a Unitary Patent
Also termed the European patent with unitary effect, the unitary patent (UP) is a single patent right covering all the states that have taken part in the …
WHICH STATES ARE IN THE UPC & WHERE WILL A UP HAVE EFFECT?
See our summary of who's currently in and who's out of the UP/UPC system below. IN: UPC participating Member States that have ratified the UPCA in …
UPC: Jurisdiction and opt-out
After the transitional period (of at least 7 years), as well as having exclusive jurisdiction over unitary patents, the UPC will have exclusive …
UPC Court Fees
The Administrative Committee of the UPC has issued a Table of Court fees document (8 July 2022; in force 1 September 2022).KEY POINTS No fees will be …
The UPC Rules
The final version of the Rules of Procedure of the Unified Patent Court (also available in French and German) came into force on 1 September 2022. One of …
UPC Structure – local, regional and central divisions and Court of Appeal
The UPC will have a Court of First Instance (divided into local, regional and central divisions) and a Court of Appeal (Luxembourg). Cases will commence …
Near enough is good enough: Full Federal Court of Australia revisits construction of “about” in patent claim
In the area of patent law, clarity is king. Where precision of language is essential for defining the limits and scope of legal rights, the acceptance …
First things first: Full Federal Court clarifies the law on patent term extensions
Last week, a Full Court of the Federal Court of Australia handed down two unanimous decisions on appeal, clearing up some key uncertainties in the …
FEDERAL COURT OVERTURNS ‘ABSURD’ PATENT OFFICE RULING ON PATENT TERM EXTENSIONS FOR PHARMACEUTICAL SUBSTANCES
The Federal Court has rejected the Australian Patent Office’s historical approach to patent term extension (PTE) applications, upholding a challenge …
Pharmaceutical patent term extensions: federal court hears challenge to “absurd” Australian patent office ruling
Two major pharmaceutical companies have challenged Australia’s Commissioner of Patents in the Federal Court about the time limits within which an …
Patent and Pharma update, February 2021
Key recent developments in the United Kingdom and Europe relating to patents and the pharmaceutical sector. In this edition we cover an important …
Showing 12 out of 54 results
View more